Levoquin: Potent Antibiotic for Severe Bacterial Infections
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.46 | $43.86 (0%) | 🛒 Add to cart |
| 60 | $1.29 | $87.72 $77.40 (12%) | 🛒 Add to cart |
| 90 | $1.12 | $131.58 $100.62 (24%) | 🛒 Add to cart |
| 120 | $0.99 | $175.44 $118.68 (32%) | 🛒 Add to cart |
| 180 | $0.86 | $263.16 $154.80 (41%) | 🛒 Add to cart |
| 270 | $0.77 | $394.74 $208.98 (47%) | 🛒 Add to cart |
| 360 | $0.75
Best per pill | $526.32 $269.18 (49%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $1.72 | $34.40 (0%) | 🛒 Add to cart |
| 30 | $1.63 | $51.60 $49.02 (5%) | 🛒 Add to cart |
| 60 | $1.55 | $103.20 $92.88 (10%) | 🛒 Add to cart |
| 90 | $1.41 | $154.80 $127.28 (18%) | 🛒 Add to cart |
| 120 | $1.29 | $206.40 $154.80 (25%) | 🛒 Add to cart |
| 180 | $1.07 | $309.60 $193.50 (38%) | 🛒 Add to cart |
| 270 | $0.97 | $464.40 $262.30 (44%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $619.20 $318.20 (49%) | 🛒 Add to cart |
Levoquin (levofloxacin) is a broad-spectrum fluoroquinolone antibiotic indicated for adults with serious bacterial infections requiring aggressive treatment. This prescription medication targets a wide range of gram-positive and gram-negative pathogens through its potent bactericidal action. Clinical evidence supports its efficacy in combating complicated urinary tract infections, community-acquired pneumonia, and skin structure infections when first-line antibiotics prove insufficient. Proper medical supervision is essential throughout the treatment course to maximize therapeutic outcomes while minimizing potential risks.
Features
- Contains levofloxacin as the active pharmaceutical ingredient
- Available in 250mg, 500mg, and 750mg oral tablets
- Also formulated as intravenous injection solution (25mg/mL)
- Demonstrated bioavailability exceeding 99%
- Broad-spectrum activity against aerobic and anaerobic bacteria
- Concentration-dependent killing mechanism
- Post-antibiotic effect lasting 1-2 hours against susceptible organisms
Benefits
- Rapid bactericidal action against resistant pathogens
- Comprehensive coverage of common and atypical respiratory pathogens
- Effective penetration into difficult-to-treat tissues and fluids
- Convenient once-daily dosing regimen improves compliance
- Demonstrated efficacy in patients with compromised immune systems
- Reduced hospitalization duration for appropriate indications
Common use
Levoquin is primarily prescribed for adults (18 years and older) with confirmed or suspected bacterial infections where the benefits outweigh potential risks. Common approved indications include complicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, or Enterococcus faecalis. It is frequently employed for community-acquired pneumonia attributable to Streptococcus pneumoniae, Haemophilus influenzae, or atypical pathogens including Mycoplasma pneumoniae. Additional approved uses encompass acute bacterial sinusitis, chronic bacterial prostatitis, complicated skin and skin structure infections, and inhalational anthrax exposure prophylaxis. Healthcare providers reserve Levoquin for situations where alternative antibiotics with better safety profiles are not appropriate.
Dosage and direction
Dosage varies significantly based on infection type, severity, renal function, and patient characteristics. For most indications, the standard adult dose is 500mg once daily, though 750mg may be prescribed for more severe infections. Treatment duration typically ranges from 7 to 14 days, extended to 28 days for chronic bacterial prostatitis. Administer tablets with a full glass of water, with or without food, though taking Levoquin 2 hours before or after antacids containing magnesium or aluminum is crucial. For patients with renal impairment (creatinine clearance <50 mL/min), dosage adjustment is mandatory according to prescribing guidelines. Complete the entire prescribed course even if symptoms improve earlier to prevent resistance development.
Precautions
Patients should immediately report tendon pain, swelling, or inflammation, as fluoroquinolones may increase rupture risk, particularly in older adults, corticosteroid users, and organ transplant recipients. Avoid excessive sunlight exposure and use protective measures due to photosensitivity reactions. Monitor blood glucose regularly in diabetic patients, as hypoglycemia and hyperglycemia have been reported. Use with caution in patients with known or suspected central nervous system disorders that may predispose to seizures or lower the seizure threshold. Peripheral neuropathy characterized by pain, burning, tingling, numbness, and/or weakness may occur rapidly and potentially become irreversible. Mental health changes including anxiety, depression, insomnia, and confusion warrant immediate medical attention.
Contraindications
Levoquin is contraindicated in patients with documented hypersensitivity to levofloxacin, other quinolone antibiotics, or any component of the formulation. Concomitant administration with tizanidine is strictly prohibited due to potentially dangerous interactions. Avoid use in patients with history of tendon disorders related to fluoroquinolone administration. Not recommended for pediatric patients, pregnant women, or nursing mothers unless no alternative exists and potential benefits justify fetal/infant risk. Patients with myasthenia gravis should not receive Levoquin due to potential exacerbation of muscle weakness.
Possible side effect
Common adverse reactions (≥1%) include nausea (7%), diarrhea (5%), headache (6%), constipation (3%), dizziness (3%), and insomnia (4%). Less frequent but clinically significant effects include tendonitis or tendon rupture (≤0.5%), peripheral neuropathy (≤0.5%), central nervous system effects (anxiety, agitation, seizures; ≤1%), and QT interval prolongation (dose-dependent). Hypersensitivity reactions ranging from rash and pruritus to anaphylaxis may occur. Clostridium difficile-associated diarrhea has been reported with all antibacterial agents, ranging from mild to life-threatening colitis. Hepatic enzyme elevations, crystalluria, nephritis, and blood glucose disturbances represent additional potential concerns.
Drug interaction
Concomitant use with nonsteroidal anti-inflammatory drugs may increase CNS stimulation and seizure risk. Antacids containing magnesium, aluminum, sucralfate, metal cations such as iron, and multivitamins containing zinc significantly reduce absorption—separate administration by at least 2 hours before or 4 hours after Levoquin. Warfarin coadministration may enhance anticoagulant effect requiring frequent INR monitoring. Drugs that prolong QT interval (antiarrhythmics, tricyclic antidepressants, macrolides) should be used cautiously. Levoquin may enhance effects of oral hypoglycemic agents and insulin. Probenecid interferes with renal tubular secretion of levofloxacin, increasing serum concentrations.
Missed dose
Take the missed dose as soon as remembered unless it is almost time for the next scheduled dose. Never double the dose to make up for a missed one. If less than 8 hours remain until the next dose, skip the missed dose and resume the regular dosing schedule. Maintaining consistent antibiotic levels is important, but taking two doses too close together increases the risk of side effects. Contact the prescribing physician if multiple doses have been missed for guidance on how to proceed with the treatment regimen.
Overdose
Symptoms may include dizziness, tremors, seizures, confusion, nausea, vomiting, and prolongation of the QT interval. ECG monitoring is recommended for observed or suspected overdose. Management consists of symptomatic and supportive care with maintenance of hydration. Hemodialysis removes approximately 14% of the administered dose over 4 hours and may be considered in severe cases. There is no specific antidote for levofloxacin overdose. Contact poison control (1-800-222-1222) or seek emergency medical attention immediately for appropriate management.
Storage
Store Levoquin tablets at controlled room temperature (20-25°C or 68-77°F) with excursions permitted between 15-30°C (59-86°F). Keep in the original container with the lid tightly closed to protect from light and moisture. Do not store in bathroom cabinets where humidity levels fluctuate. Keep out of reach of children and pets. Discard any unused medication after completing the prescribed course. Do not flush medications down the toilet or pour down a drain unless instructed to do so. Consult a pharmacist about proper disposal methods.
Disclaimer
This information does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about your medication regimen. Never disregard professional medical advice or delay seeking it because of information contained in this document. The content provided is for informational purposes only and reflects data available at the time of publication. Individual patient responses to medication vary, and only a healthcare professional can assess specific medical situations.
Reviews
Clinical studies demonstrate Levoquin’s efficacy with 85-92% clinical success rates across approved indications. Many physicians report satisfactory outcomes in complicated infections when used appropriately. However, healthcare providers increasingly reserve fluoroquinolones for cases with limited alternatives due to safety concerns. Patient experiences vary significantly, with some reporting rapid resolution of serious infections while others describe challenging side effects. The medical community continues to debate the risk-benefit profile, particularly for less severe infections where safer alternatives exist.